KEMIFARMA Consulting ApS: Financial statements 2019
CVR: 34709955
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -31,977 and a net result of DKK 176,373 compared with DKK -78,923 the year before. Equity in the 2019 report amounted to DKK 2,446,488. The solvency ratio was 99.1%.
- Gross Profit
- DKK -31,977
- Profit/Loss
- DKK 176,373
- Equity
- DKK 2,446,488
- Total Assets
- DKK 2,467,725
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -32K | 176K | 2.4M | - |
| 2018 | - | -23K | -79K | 2.3M | - |
| 2017 | - | -11K | 191K | 2.4M | - |
| 2016 | - | -13K | 4K | 2.3M | - |
| 2015 | - | -12K | 352K | 2.3M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
KEMIFARMA Consulting ApS has published its annual report for 2018. Gross profit came to DKK -23,431, and the net result was DKK -78,923.
About KEMIFARMA Consulting ApS
KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.